InvestorsHub Logo
Followers 171
Posts 18377
Boards Moderated 2
Alias Born 11/29/2010

Re: None

Monday, 07/17/2023 11:03:42 PM

Monday, July 17, 2023 11:03:42 PM

Post# of 34895
Stuff FINRA might question. In their Q1 2023 another ticker reports---

4) Issuer’s Business, Products and Services

The purpose of this section is to provide a clear description of the issuer’s current operations. (Please ensure that these descriptions are updated on the Company’s Profile on www.otcmarkets.com)

B. List any subsidiaries, parent company, or affiliated companies.
Plandai Biotechnology
(Page 8)

--it also names--

McCallum Trust/ Baylis Duffied
>>CEO<< of Plandai Biotechnology
(Page 9)
17 Hanover Square, London, England
Control person: Baylis Duffied. On May 1, 2020 Plandai Biotechnology, Inc., the entity from which Plandai Biotechnology South Africa was acquired, agreed to return and cancel all Series D shares due to breach of contract https://www.otcmarkets.com/otcapi/company/financial-report/371606/content

This is from a disclosure posted on 5/20/2023-- less than two months ago-- claiming that Plandai is a "subsidiary, parent company, or affiliated company" of THEIRS.

So what you have are two tickers --one claiming it's all cleaned up, audited and not a shell ---and another recently claiming PLANDAI is still part of THEIR dumpster fire. If Tad cleared that up then why is the other ticker saying otherwise? Even being a "caveat emptor" ticker their stock is valued at more than TWICE that of PLPL (up +14.3% today at .0008 vs .0003) with a slightly higher O/S (8.4 vs 8.2 billion) and an A/S that's a billion LESS than PLPL's.
https://www.otcmarkets.com/stock/TXTM/security

Do not buy, sell or make any investment decision based any information or opinion I post. Conduct your own DD.